Table 1.
Biomarker Candidate |
Sample Source | Quantitative Method | Function | Changes during Neuropathy | Literature |
---|---|---|---|---|---|
(a) AGEs related | |||||
Methylglyoxal | Human serum | HPLC | Post-translational modification of voltage-gated sodium channel Nav 1.8 causes hyperalgesia. In addition, it activates TRPA1 and induces temperature and mechanical hyperalgesia. | When administered to mice, hyperalgesia due to thermal and mechanical stimulation is induced. | [14,15,16,17,18,19,20] |
Glyoxalase I (GLO I) | Mouse DRG Human serum |
Colorimetric method | A rate-limiting enzyme that decomposes reactive dicarbonyls such as methylglyoxal | The neuropathic symptoms observed in diabetic conditions are significantly suppressed in mice with high GLO I activity. In humans, decreased GLO I activity is also significantly correlated with the frequency of painful neuropathy | [21,22,23,24,25] |
(b) Inflammation-related molecules | |||||
TNF-α | Human serum | ELISA | Expression of cell adhesion molecules and induction of apoptosis Increased inflammatory mediator | It is elevated in type 2 diabetic patients in the control group and in the diabetic and neuropathy group compared to the diabetic group | [28,29] |
TLR4 | Human peripheral blood mononuclear cells |
qPCR | Receptors involved in innate immunity |
It is elevated in type 2 diabetic patients in the control group and in the diabetic and neuropathy group compared to the diabetic group | [30,31,32,33,34] |
Adiponectin | Human serum | ELISA | Adipocytokines produced and secreted by adipocytes | There is a significant difference between the control group and the diabetic group with neuropathy compared with the control group in type 2 diabetic patients (the distinction differs depending on the report). | [36,37,38] |
miR-146a | Human Serum Mouse DRG |
qPCR | Negative feedback on inflammatory response | It is elevated in patients with type 2 diabetes, but its association with neuropathy has not been investigated. In diabetic neuropathy mice, the expression level in the DRG is reduced, and the forced expression in the DRG after culture acquires resistance to hyperglycemia-induced apoptosis. | [40,41] |
(c)Molecules associated with nerve damage | |||||
Nerve-specificenolase (NSE) | Human serum | ELISA | Glycolytic enzymes specific to nerve tissue (Leakage due to nerve damage) |
It is elevated in type 1 and type 2 diabetic patients compared to the control group, especially in the group with neuropathy. | [47,48] |
Semaphorin | Mouse sciatic nerve |
qPCR | Nerve axon elongation guidance factor | These mRNAs are induced in the sciatic nerve in a rat sciatic nerve ligation model. |
[52,53,54,55] |
(d) Molecules involved in neuroprotection | |||||
NGF | Human serum | ELISA | Neurotrophic factors involved in nerve regeneration | It is lower in type 2 diabetic patients in the control group and in the diabetic and neuropathy group than in the diabetic group | [56,57,58,59] |
HSP27 | Human serum | ELISA | Cell protective factors in the presence of stress | It is elevated in type 1 and type 2 diabetic patients compared to the control group, especially in the group with neuropathy. | [60,61,62,63,64] |